Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1981 2
1988 1
1989 4
1990 7
1991 1
1993 4
1994 3
1995 6
1996 7
1997 12
1998 9
1999 14
2000 20
2001 26
2002 33
2003 41
2004 45
2005 52
2006 56
2007 55
2008 85
2009 99
2010 133
2011 126
2012 128
2013 161
2014 189
2015 187
2016 155
2017 194
2018 217
2019 281
2020 263
2021 257
2022 121
Text availability
Article attribute
Article type
Publication date

Search Results

2,653 results
Results by year
Filters applied: . Clear all
Page 1
Nephritic Syndrome.
Lamba P, Nam KH, Contractor J, Kim A. Lamba P, et al. Among authors: nam kh. Prim Care. 2020 Dec;47(4):615-629. doi: 10.1016/j.pop.2020.08.003. Epub 2020 Sep 25. Prim Care. 2020. PMID: 33121632 Review.
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.
Balar AV, Kamat AM, Kulkarni GS, Uchio EM, Boormans JL, Roumiguié M, Krieger LEM, Singer EA, Bajorin DF, Grivas P, Seo HK, Nishiyama H, Konety BR, Li H, Nam K, Kapadia E, Frenkl T, de Wit R. Balar AV, et al. Among authors: nam k. Lancet Oncol. 2021 Jul;22(7):919-930. doi: 10.1016/S1470-2045(21)00147-9. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051177 Clinical Trial.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Powles T, et al. Among authors: nam k. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051178 Clinical Trial.
Resetting proteostasis with ISRIB promotes epithelial differentiation to attenuate pulmonary fibrosis.
Watanabe S, Markov NS, Lu Z, Piseaux Aillon R, Soberanes S, Runyan CE, Ren Z, Grant RA, Maciel M, Abdala-Valencia H, Politanska Y, Nam K, Sichizya L, Kihshen HG, Joshi N, McQuattie-Pimentel AC, Gruner KA, Jain M, Sznajder JI, Morimoto RI, Reyfman PA, Gottardi CJ, Budinger GRS, Misharin AV. Watanabe S, et al. Among authors: nam k. Proc Natl Acad Sci U S A. 2021 May 18;118(20):e2101100118. doi: 10.1073/pnas.2101100118. Proc Natl Acad Sci U S A. 2021. PMID: 33972447 Free PMC article.
The lung microenvironment shapes a dysfunctional response of alveolar macrophages in aging.
McQuattie-Pimentel AC, Ren Z, Joshi N, Watanabe S, Stoeger T, Chi M, Lu Z, Sichizya L, Aillon RP, Chen CI, Soberanes S, Chen Z, Reyfman PA, Walter JM, Anekalla KR, Davis JM, Helmin KA, Runyan CE, Abdala-Valencia H, Nam K, Meliton AY, Winter DR, Morimoto RI, Mutlu GM, Bharat A, Perlman H, Gottardi CJ, Ridge KM, Chandel NS, Sznajder JI, Balch WE, Singer BD, Misharin AV, Budinger GRS. McQuattie-Pimentel AC, et al. Among authors: nam k. J Clin Invest. 2021 Feb 15;131(4):e140299. doi: 10.1172/JCI140299. J Clin Invest. 2021. PMID: 33586677 Free PMC article.
Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates.
Hong SH, Oh H, Park YW, Kwak HW, Oh EY, Park HJ, Kang KW, Kim G, Koo BS, Hwang EH, Baek SH, Park HJ, Lee YS, Bang YJ, Kim JY, Bae SH, Lee SJ, Seo KW, Kim H, Kwon T, Kim JH, Lee S, Kim E, Kim Y, Park JH, Park SI, Gonçalves M, Weon BM, Jeong H, Nam KT, Hwang KA, Kim J, Kim H, Lee SM, Hong JJ, Nam JH. Hong SH, et al. Among authors: nam kt. Sci Adv. 2021 May 28;7(22):eabg7156. doi: 10.1126/sciadv.abg7156. Print 2021 May. Sci Adv. 2021. PMID: 34049881 Free article.
2,653 results